BRPI1003652C1 - pharmaceutical composition for the treatment of cancer from active ingredients isolated from psidium guajava l - Google Patents

pharmaceutical composition for the treatment of cancer from active ingredients isolated from psidium guajava l

Info

Publication number
BRPI1003652C1
BRPI1003652C1 BRPI1003652A BRPI1003652C1 BR PI1003652 C1 BRPI1003652 C1 BR PI1003652C1 BR PI1003652 A BRPI1003652 A BR PI1003652A BR PI1003652 C1 BRPI1003652 C1 BR PI1003652C1
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
psidium guajava
cancer
treatment
active ingredients
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Carvalho Joao Ernesto De
Larissa Yokota Rizzo
Mary Ann Foglio
Gois Ruiz Ana Lecia Tasca
Adilson Sartoratto
Glyn Mara Figueira
Eberlin Marcos Nogueira
Konradin Metze
Original Assignee
Unicamp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unicamp filed Critical Unicamp
Priority to BRPI1003652 priority Critical patent/BRPI1003652C1/en
Publication of BRPI1003652A2 publication Critical patent/BRPI1003652A2/en
Publication of BRPI1003652C1 publication Critical patent/BRPI1003652C1/en

Links

Abstract

COMPOSIÇçO FARMACÊUTICA PARA O TRATAMENTO DE CÂNCER A PARTIR DE PRINCÍPIOS ATIVOS ISOLADOS DE PSIDIUM GUAJAVA L. O presente Certificado de Adição refere-se a uma composição farmacêutica que compreende a molécula psidial A. (m/z=474, íon base=271) obtida da espécie vegetal Psidium guajava L. (nome popular: goiabeira) da família Mytaceae, que possui atividade anticâncer.PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT FROM ISOLATED ACTIVE PRINCIPLES OF PSIDIUM GUAJAVA L. This Certificate of Addition refers to a pharmaceutical composition comprising psidial molecule A. (m / z = 474, base ion = 271) obtained of the plant species Psidium guajava L. (popular name: guava) of the Mytaceae family, which has anticancer activity.

BRPI1003652 2010-09-15 2010-09-15 pharmaceutical composition for the treatment of cancer from active ingredients isolated from psidium guajava l BRPI1003652C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI1003652 BRPI1003652C1 (en) 2010-09-15 2010-09-15 pharmaceutical composition for the treatment of cancer from active ingredients isolated from psidium guajava l

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1003652 BRPI1003652C1 (en) 2010-09-15 2010-09-15 pharmaceutical composition for the treatment of cancer from active ingredients isolated from psidium guajava l

Publications (2)

Publication Number Publication Date
BRPI1003652A2 BRPI1003652A2 (en) 2013-01-08
BRPI1003652C1 true BRPI1003652C1 (en) 2013-09-24

Family

ID=47469677

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1003652 BRPI1003652C1 (en) 2010-09-15 2010-09-15 pharmaceutical composition for the treatment of cancer from active ingredients isolated from psidium guajava l

Country Status (1)

Country Link
BR (1) BRPI1003652C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107602524A (en) * 2017-06-07 2018-01-19 中国科学院昆明植物研究所 The miscellaneous terpenoid of formyl phloroglucin and its pharmaceutical composition and its preparation method and application

Also Published As

Publication number Publication date
BRPI1003652A2 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
ECSP12012318A (en) PIRAZOLIL QUINAZOLINA CINASA INHIBITORS
BR112014000792A2 (en) Piperidinyl Compounds for Use as Tanquirase Inhibitors
BRPI0910388A2 (en) antiviral therapeutic agents.
ECSP14013325A (en) PIRIDOPIRAZINAS ANTICANCERIGENAS VIA THE INHIBITION OF FIBROBLASTO GROWTH FACTOR RECEPTOR (FGFR) INHIBITION
BR112013033182A2 (en) substituted imidazopyridinyl aminopyridine compounds
BR112015011456A2 (en) aminopyrimidine compounds as t790m-containing mutant egfr inhibitors
CO6511271A2 (en) IMIDAZOPIRIDINIL-AMINOPIRIDINE SUBSTITUTED COMPOUNDS
BR112014013526A8 (en) antibody-drug conjugates and related compounds, compositions and methods
CO6670575A2 (en) Substituted aminopyrazoloqinazolines, useful in the treatment of proliferative diseases and pharmaceutical compositions that continue them
BR112014026703A2 (en) dna-pk inhibitors
EA201190235A1 (en) SUBSTITUTED 1-CYANOETHYLGETHERO CYCLILCARBOXAMIDE COMPOUNDS 750
BR112014018027A8 (en) COMPOUND, PHARMACEUTICAL COMPOSITION AND USES THEREOF, AND METHODS FOR ENHANCEING INCLUSION OF AME2 EXON 7 INTO RNAM THAT IS TRANSCRIBED FROM THE AME2 GENE AND FOR INCREASING THE AMOUNT OF SMN PROTEIN
EA201001205A1 (en) COMPOUNDS CONTAINING CYCLOBUTOXY GROUP
UY33246A (en) TIENOPIRIMIDINES CONTAINING CYCLLOQUAL FOR PHARMACEUTICAL COMPOSITIONS
CO7310531A2 (en) 4-methyl-2,3,8,9,9b-pentaaza-cyclopenta [a] naphthalenes
CR20110255A (en) NEW COMPOUNDS 578
MY148948A (en) Catecholamine derivatives and prodrugs thereof
UY30220A1 (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
IN2012DN02139A (en)
CO6470899A2 (en) 2,4-DIAMINOPIRIMIDINES FOR THE TREATMENT OF CHARACTERIZED DISEASES BY EXCESSIVE OR NORMAL CELL PROLIFERATION
DOP2015000005A (en) DERIVATIVES OF ESTRA 1,3,5 (10), 16 TETRAENE 3 SUBSTITUTES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
WO2013040227A3 (en) Therapeutic compounds
EA201001855A1 (en) COMPOUNDS CONTAINING CYCLOBUTOXY GROUP
WO2014035846A3 (en) Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
WO2015042414A8 (en) Multicyclic compounds and methods of using same

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REFERENTE A RPI 2192 DE 08/01/2013, QUANTO AO ITEM (51).

B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06V Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B03G Publication of an application: publication cancelled [chapter 3.7 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: ANULADA A PUBLICACAO CODIGO 3.1 NA RPI NO 2229 DE 24/09/2013 POR TER SIDO INDEVIDA.

B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2466 DE 10/04/2018 POR TER SIDO INDEVIDA.

B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B11Q Dismissal: the certificate of addition was not accessory to any patent, or a patent which was nominated accessory and no longer exists

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: CONFORME O ESTABELECIDO NA NORMA DE EXECUCAO NO 01/13 DE 18/03/13 EM SEU ARTIGO 5O, ARQUIVO O PRESENTE PEDIDO FACE AO INDEFERIMENTO DEFINITIVO DO PEDIDO PRINCIPAL CONFORME DESPACHO 9.2.4 PUBLICADO NA RPI NO 2620 DE 23/03/2021, DE ACORDO COM O DISPOSTO NO ART. 77 DA LPI (LEI 9279 / 96) DE 14/05/1996.PUBLIQUE-SE O ARQUIVAMENTO (11.17).

B11T Dismissal: dismissal of application maintained

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: